Palynziq
Chemical Name | pegvaliase-pqpz |
Dosage Form | Injectable (subcutaneous; 2.5 mg/0.5 mL, 10 mg/0.5 mL, 20 mg/mL) |
Drug Class | Enzymes |
System | Blood |
Company | BioMarin Pharmaceutical Inc. |
Approval Year | 2018 |
Indication
- Palynziq is indicated to reduce blood phenylalanine concentrations in adult patients with phenylketonuria who have uncontrolled blood phenylalanine concentrations greater than 600 micromol/L on existing management.